MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)

Meeting: 2018 International Congress

Abstract Number: 165

Keywords: Dystonia: Clinical features, Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Saturday, October 6, 2018

Session Title: Neuroimaging (Non-PD)

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To investigate whether alterations of cortical thickness correspond to cognitive dysfunction in XDP patients.

Background: X-linked dystonia-parkinsonism (XDP) is a severe, hereditary movement disorder characterized by a combination of adult-onset dystonia and subsequent parkinsonism. Aside from motor manifestations, executive and other cognitive functions are impaired in XDP (1). Prior studies have shown extensive striatal neurodegeneration and mildly reduced cortical thickness in the frontal and temporal cortex (2).

Methods: MRI scans were acquired in 17 male XDP patients from the Philippines (40.1±7.5 years) and 17 ethnicially matched male controls (35.2±7.4 years). ROI-labeled cortical thickness was calculated after auto-segmentation of preprocessed T1-weighted images via the Mindboggle software as a cross-platform Docker container (3). ROIs were defined using a modified Desikan-Killiany-Tourville labelling protocol. A priori defined ROIs for the DLPFC, pre-SMA, ACC, anterior insular cortex (AIC), inferior frontal junction (IFJ), premotor cortex (PMC), and posterior parietal cortex (PPC) were analyzed. The cuneus has been chosen as a control ROI as this region is not involved in cognitive functions. Clinical assessment of cognitive domains was performed by trained healthcare professionals using MoCA, MMSE, and Frontal Assessment Battery (FAB).

Results: There were significant group differences for the DLPFC (-3.64%; p=.022), pre-SMA (-4.17%; p=.033), AIC (-3.46%; p=.013), IFJ (-5.04%; p=.013), and PMC (-5.82%; p=.010). All of them were significantly correlated with the MMSE (DLPFC: r=.597, p=.031; pre-SMA: r=.604, p=.029; AIC: r=.824, p<.001; IFJ: r=.755, p<.001; PMC: r=.778, p=.002). In addition, the PMC and IFJ correlated with the MoCA (r=.596, p=.032 and r=.496, p=.043) and the IFJ with the FAB (r=.554, p=.026). Cortical thickness of PPC and cuneus was not reduced in patients. None of the cognitive tests correlated with cortical thickness of the PPC and cuneus.

Conclusions: Cortical thinning is present in the frontal cortex of XDP patients but mild in comparison to the remarkable striatal decline. Cognitive assessments correlated with the degree of cortical thickness in the patients. Although cortical alterations are most likely a secondary effect of striatal neurodegeneration, we were able to demonstrate the potential use of preselected ROIs as a neuroimaging marker for cognitive decline in XDP.

References: (1) Howe, L. L., Kellison, I. L., Fernandez, H. H., Okun, M. S., & Bowers, D. (2009). Neuropsychological Profile of a Filipino Gentleman with X-Linked Dystonia–Parkinsonism: A Case Report of Lubag Disease. The Clinical Neuropsychologist, 23(1), 100-117. (2) Brüggemann, Norbert, et al. “Neuroanatomical changes extend beyond striatal atrophy in X-linked dystonia parkinsonism.” Parkinsonism & related disorders 31 (2016): 91-97. (3) Klein, Arno, and Joy Hirsch. “Mindboggle: a scatterbrained approach to automate brain labeling.” NeuroImage 24.2 (2005): 261-280.

To cite this abstract in AMA style:

J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann. Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/cortical-thinning-as-a-neuroimaging-marker-of-cognitive-decline-in-x-linked-dystonia-parkinsonism/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cortical-thinning-as-a-neuroimaging-marker-of-cognitive-decline-in-x-linked-dystonia-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley